Evotec’s Advanced Cell Line Development (CLD) platform delivers integrated, CRISPR-enabled solutions from gene design to fully banked, production-ready clones. With over 20 years of expertise and more than 200 stable cell lines generated annually, Evotec combines vector engineering, genome editing, and optimized selection strategies to ensure predictable expression, reproducibility, and manufacturability.

Key Highlights:

• Integrated CLD Workflow – Gene delivery to clone isolation and banking
• CRISPR/Cas9 Engineering – Targeted knock-out/knock-in with validation
• Flexible Expression – Transient and stable gene modulation
• Optimized Vectors & Delivery – Promoter and stability-focused design
• Efficient Selection – Maximized high-performing clone recovery

This platform enables rapid progression from concept to clinic, aligning gene modulation strategies with defined biological and development objectives. Download the fact sheet to learn more!